Compounds > 1,4,7-triazacyclononane-n,n',n''-triacetic acid
Page last updated: 2024-09-03

1,4,7-triazacyclononane-n,n',n''-triacetic acid and n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine

1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine in 1 studies

Compound Research Comparison

Studies
(1,4,7-triazacyclononane-n,n',n''-triacetic acid)		Trials
(1,4,7-triazacyclononane-n,n',n''-triacetic acid)		Recent Studies (post-2010)
(1,4,7-triazacyclononane-n,n',n''-triacetic acid)		Studies
(n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine)		Trials
(n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine)		Recent Studies (post-2010) (n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine)
19531614010167

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Shi, J; Tong, R; Wang, T; Xiong, L; Xu, K; Zhao, L1

Reviews

1 review(s) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine

ArticleYear
Recent research and development of NDM-1 inhibitors.
    European journal of medicinal chemistry, 2021, Nov-05, Volume: 223

    Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Catalytic Domain; Drug Resistance, Bacterial; Molecular Docking Simulation; Picolinic Acids; Sulfonamides

2021